Donald Blair

2015009, Apr 2, 2015

Sep 29, 2013

14/040723

Cynthia Washington - Stone Mountain GA, US
Aaron Gardner - Atiarta GA, US
Rashaad White - Stone Mountain GA, US
Donald Blair - Atlanta GA, US

B65D 21/02
G09F 3/00
B65D 41/04

220 234, 220288, 220669, 2064595, 220 2383

The current invention comprises fractionally proportioned, nesting containers with a banded, carrying element. Said containers hold liquids, such as carbonated soft drinks, alcoholic beverages, teas, water, etc., in addition to non-liquid goods, ranging from dry recipe ingredients to personal hygiene products. The individual bottles can be manufactured out of glass, metals, alloys and various plastics and sizes of the individual bottles, in the nested unit, are not limited. Container contents determine the fractional proportions of unit and bottle sizes therewith. Said unit accommodates the end user with prepackaged quantities of contents. The configuration of the current invention, permits the end user(s) desiring the same product, within the bottles of said unit, the option to open them separately, in order to sustain freshness of unopened portion(s), further allowing end user to exercise a level of control with regards to amount of product consumption and variety of the contents thereof.

D375181, Nov 5, 1996

Nov 16, 1994

D/031060

David F. Tourney - Quincy IL
Donald J. Blair - Quincy IL
Melvin L. Maas - Quincy IL
Mark S. Eickelschulte - Quincy IL

Moorman Manufacturing Company - Quincy IL

D 1100

5856125, Jan 5, 1999

Jun 5, 1995

8/469412

George J. Mavrothalassitis - Frederick MD
Donald G. Blair - Kensington MD
Robert J. Fisher - Sharpsburg MD
Gregory J. Beal - New Market MD
Meropi A. Athanasiou - Frederick MD
Dionyssios N. Sgouras - Athens, GR

The United States of America as represented by the Department of Health
and Human Services - Washington DC

C12N 1512
C12N 1509
C07K 1447
C07K 1482

435 691

The present invention relates, inter alia, to the ERF gene and to the products encoded by this gene. More particularly, the present invention relates to DNA sequences encoding ERF and AERF; polypeptides encoded by such DNA sequences; ERF chimeric molecules; and methods of using ERF and ERF chimeric molecules to reduce tumorigenicity in a tumor cell.

2008007, Mar 20, 2008

Sep 18, 2006

11/525193

Donald John Blair - Farmington NM, US
Kenneth Richard Brackett - Farmington NM, US

A63B 57/00

473282

A golf club stand made from one piece of round rod that sticks into the ground providing many services. The stand can be used for many purposes, the device will hold up to 8 plus clubs along with the flag stick, the device will hold a wet towel and club covers. The device can be used during many instances such as when carts are not allowed in the fairway during winter months and you need to take three or more clubs, when the grass is wet and you do not want to get your grips wet, when you have to take multiple clubs to the green for a chip or sand shot, when you have a bad back and do not want to bend over, when you go to the driving range during a tournament and you take four or five clubs as you can not take your entire bag. With this device and the way you stick it into the ground you can virtually hang everything on the stand during your time on the green and not have to bend over to pick up any equipment including the flag during your trip to the green. This is a very simple device that provides many services during a round of golf and will last forever if kept in the bag with the putter. The device also helps prevent club loss where you leave a club on the edge of a green or in the grass outside the green to later discover you left it and have to go back to find it or replace it.

2003007, Apr 24, 2003

Dec 27, 2001

10/033717

Donald Blair - Frederick MD, US
Peter Clausen - Frederick MD, US
Lilia Topol - Frederick MD, US
Maria Marx - L'Hay Les Roses, FR
Georges Calothy - Orsay, FR

The Government of the U.S.A., as represented by the Secretary, Dept. of Health & Human Services

C07K014/705
C07H021/04
C12P021/02
C12N005/06

536/023500, 530/350000, 435/069100, 435/325000, 435/320100

The present invention provides an isolated nucleic acid encoding DRM protein, an isolated DRM polypeptide, and a fusion polypeptide comprising a DRM protein and a green fluorescent protein. The present invention also provides a method of arresting the growth of a cell, comprising administering to the cell an effective amount of DRM protein or an active fragment thereof; a method of inhibiting tumor cell growth, comprising administering to a tumor cell an effective amount of DRM protein or an active fragment thereof; and a method of treating a hyperproliferative cell disorder in a subject diagnosed with a hyperproliferative cell disorder, comprising administering to the subject an effective amount of DRM protein or an active fragment thereof, in a pharmaceutically acceptable carrier. In addition, the present invention provides a method of arresting growth of a cell, comprising administering to the cell an effective amount of a nucleic acid encoding a DRM protein or an active fragment thereof, a method of inhibiting tumor cell growth, comprising administering to a tumor cell an effective amount of a nucleic acid encoding a DRM protein or an active fragment thereof; and a method of treating a hyperproliferative cell disorder in a subject diagnosed with a hyperproliferative cell disorder, comprising administering to a cell of the subject, in a pharmaceutically acceptable carrier, an effective amount of a nucleic acid encoding a DRM protein or an active fragment thereof, under conditions whereby the nucleic acid is expressed in the subject's cell.

6194547, Feb 27, 2001

Feb 10, 1998

9/021715

George J. Mavrothalassitis - Frederick MD
Donald G. Blair - Kensington MD
Robert J. Fisher - Sharpsburg MD
Gregory J. Beal - New Market MD
Meropi A. Athanasiou - Frederick MD
Dionyssios N. Sgouras - Athens, GR

The United States of America as represented by the Department of Health and
Human Services - Washington DC

C07K 100

530350

The present invention relates, inter alia, to the ERF gene and to the products encoded by this gene. More particularly, the present invention relates to DNA sequences encoding ERF and AERF; polypeptides encoded by such DNA sequences; ERF chimeric molecules; and methods of using ERF and ERF chimeric molecules to reduce tumorigenicity in a tumor cell.

4405712, Sep 20, 1983

Jul 1, 1981

6/279443

George F. Vande Woude - Berryville VA
William L. McClements - Silver Spring MD
Marianne K. Oskarsson - Bethesda MD
Donald G. Blair - Kensington MD

The United States of America as represented by the Department of Health
and Human Services - Washington DC

C12Q 170
C12P 2100
C12P 2102
C12N 1500
C12N 500
C12N 100
C12N 700

435 5

The production of vectors composed of portions of retrovirus, particularly of Moloney sarcoma virus DNA including the "LTR" sequence which can activate genes and additional viral sequences which can "rescue" these genes into a replicating virus particle.

5422344, Jun 6, 1995

May 8, 1990

7/520456

Esther Priel - Beer Sheva, IL
Donald G. Blair - Kensington MD
Stephen D. Showalter - Frederick MD

The United States of America as represented by the Secretary of the
Department of Health & Human Services - Washington DC

A61K 3170

514 50

The present invention is directed to the use of pharmaceutical compositions, containing an effective amount of topoisomerase I inhibitor such as camptothecin, useful in blocking both the initiation of infection and replication of retroviruses in host cells, thus reducing and eliminating retroviral production in infected cells. Use of such inhibitors provides as means of reducing or eliminating retroviral infections and their deleterious consequences in infected humans and animals.